SENSEX NIFTY
81287.19 25496.55
-961.42 (-1.17%)
14.05 (0.06%)
 
   A+   I A   I A-   I Skip to main content   I Advisory for investors  I FTP Login   I List of AP  I SMARTODR   I     Webmail

NOTICES

Heading View
  SEBI Circular No. CIR/MRD/DP/01/2014 Dated 7th January, 2014   Click here
  SEBI Circular No. SEBI/HO/MIRSD/MIRSD2/CIR/P/2016/95, Dated 26th September, 2016.   Click here
DETACH
Increase
Minus
Friday, February 27, 2026  SENSEX  : 81287.19  [-961.42]     -  Adani Ports : 1520.85   [-29.75]      Asian Paints : 2376.25   [-18.75]      Axis Bank : 1383.85   [-10.85]      Bajaj Finance : 996.50   [-16.25]      Bajaj Finserv : 1992.70   [-48.65]      Bharat Electron : 444.45   [-4.55]      Bharti Airtel : 1879.75   [-48.75]      Eternal : 246.45   [+0.05]      HCL Technologies : 1390.20   [+16.75]      HDFC Bank : 887.40   [-11.45]      Hind. Unilever : 2338.25   [-45.40]      ICICI Bank : 1379.00   [-25.95]      Infosys : 1299.95   [+10.60]      Interglobe Aviat : 4823.05   [-114.40]      ITC : 313.60   [-4.60]      Kotak Mah. Bank : 415.30   [-9.25]      Larsen & Toubro : 4280.55   [-5.35]      M & M : 3399.90   [-84.15]      Maruti Suzuki : 14869.55   [-343.50]      NTPC : 381.85   [0.00]      Power Grid Corpn : 298.75   [-4.75]      Reliance Industries : 1394.30   [-11.15]      SBI : 1202.00   [-7.20]      Sun Pharma.Inds. : 1738.10   [-46.50]      Tata Steel : 212.35   [-3.15]      TCS : 2636.40   [-11.30]      Tech Mahindra : 1357.25   [-4.55]      Titan Company : 4328.40   [-12.85]      Trent : 3900.15   [+42.40]      UltraTech Cem. : 12680.25   [-253.85]      
  
Fund House Category Scheme
  
Scheme Profile  
Summary Info
Fund Name : Nippon India Mutual Fund
Scheme Name : Nippon India Pharma Fund (IDCW)
AMC : Nippon India Mutual Fund
Type : Open
Category : Equity - Pharma
Launch Date : 10-May-2004
Fund Manager : Sailesh Raj Bhan
Net Assets:(Rs cr) 7875.40
NAV Details
NAV Date : 27-Feb-2026
NAV [Rs]: 111.23
Buy/Resale Price [Rs] : 0.00
Sell/Repurchase Price [Rs] : 0.00
Entry Load % : NIL
Exit Load % : 1% if redeemed or switched out on or before completion of 1 Months from the date of allotment of units. Nil if redeemed or switched out after the completion of 1 Months from the date of allotment of units.
NAV Chart
Latest Payouts
  Dividends Bonus
Ratio 85 % NA
Date 05-Feb-2026 NA
Investment Details
Tax benefits : NA
Min. Investment(Rs) : 5000
Increm.Investment(Rs) : 1000
Performance(%) Date : 26-Feb-2026
  1 Week 1 Month 3 Month 6 Month 1 Year 3 Year 5 Year Since Inception
Scheme Return 2.71 6.93 0.19 1.13 12.11 24.35 16.46 19.80
Category Avg 2.57 6.96 -0.63 0.18 12.03 24.94 16.70 13.91
Category Best 3.69 10.29 2.73 4.44 20.47 29.05 19.09 29.03
Category Worst 0.73 1.44 -4.37 -5.30 1.40 20.30 12.79 -3.33
Asset Allocation
Sector Allocation
Holdings 31-Jan-2026
Company Name Sector Market Value No. Of Shares Hold
    Rs Cr.   %
Sun Pharma.Inds. Pharmaceuticals 998.08 6256349 12.67
Lupin Pharmaceuticals 620.87 2883991 7.88
Divi's Lab. Pharmaceuticals 514.79 850754 6.54
Dr Reddy's Labs Pharmaceuticals 477.02 3916074 6.06
Cipla Pharmaceuticals 462.75 3495054 5.88
Apollo Hospitals Healthcare 451.59 648795 5.73
Medplus Health Retail 289.80 3627277 3.68
Vijaya Diagnost. Healthcare 276.75 2886684 3.51
Ajanta Pharma Pharmaceuticals 266.87 959323 3.39
Glaxosmi. Pharma Pharmaceuticals 219.32 913226 2.78
Sai Life Pharmaceuticals 213.44 2555745 2.71
Aurobindo Pharma Pharmaceuticals 205.63 1702630 2.61
Abbott India Pharmaceuticals 204.50 74187 2.60
Ipca Labs. Pharmaceuticals 200.73 1364742 2.55
Mankind Pharma Pharmaceuticals 192.68 907154 2.45
J B Chemicals & Pharmaceuticals 186.88 999649 2.37
Thyrocare Tech. Healthcare 184.47 4392120 2.34
Alkem Lab Pharmaceuticals 183.77 323678 2.33
Dr Lal Pathlabs Healthcare 171.71 1218224 2.18
Narayana Hrudaya Healthcare 163.34 923911 2.07
Gland Pharma Pharmaceuticals 147.83 800549 1.88
Pfizer Pharmaceuticals 145.24 318249 1.84
Max Healthcare Healthcare 118.77 1241340 1.51
Emcure Pharma Pharmaceuticals 109.25 746337 1.39
Suraksha Diagno. Healthcare 103.62 3896349 1.32
Fortis Health. Healthcare 94.00 1103889 1.19
Sanofi India Pharmaceuticals 92.52 230272 1.17
Sanofi Consumer Pharmaceuticals 90.74 213659 1.15
Syngene Intl. Healthcare 89.17 1883372 1.13
Biocon Pharmaceuticals 81.41 2219374 1.03
Akums Drugs Pharmaceuticals 66.60 1515264 0.85
Anthem Bioscienc Pharmaceuticals 63.44 1058503 0.81
Astrazeneca Phar Pharmaceuticals 53.50 62568 0.68
Indoco Remedies Pharmaceuticals 39.91 1834924 0.51
Concord Biotech Pharmaceuticals 13.13 111738 0.17
TREPS Debt Others 90.82 0 1.15
Net CA & Others Debt Others -9.56 0 -0.11
C C I Debt Others 0.07 0 0.00
Statistical Ratios
What is Beta ?
Beta is a measure of the volatility of the portfolio to that of the index. In simple words it shows the movement of the portfolio in comparison. The Higher the Beta, higher the volatility of the scheme to the index. If its greater than1 , then the portfolio is highly volatile to the movemnts in the index. If the beta is lesser than 1 , then scheme is less volatile to the index and beta which is close to 1 implies that the scheme is closely following the index.
Beta [%]* SD [%]* Sharpe Ratio [%]* Jensons Alpha [%]* ER [%]*
0.8666 4.3589 1.0086 9.8694 -0.0109
 
Attention Investors: No need to issue cheques by investors while subscribing to IPO. just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account. | Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day......................issued in the interest of investors.' "
"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."
Dear Clients: We are here with requesting you to submit your separate e-mail id to receive communications/reports, by submitting account modification form in this regards or if you have registered your family member e-mail id with us, please submit declaration in this regards. Further, if you have not registered e-mail id/mobile number with us, please register it by submitting account modification form which facilitates you to receive all the data/reports electronically. If you require any clarification, please feel free to call Mr. Hemant Shah on 9004603818 or email us at kyc@swcapital.in
Feedback | Back Office | Downloads | KYC | Disclaimer | Privacy Policy | Investor Grievances |
INVESTOR CHARTER |
INVESTOR CHARTER-STOCK BROKER INVESTOR CHARTER-DEPOSITORY PARTICIPANTS INVESTOR CHARTER–KYC
Communique | Tariff Structure |
INVESTOR COMPLAINTS DETAILS|
Month End Month-Wise Year-Wise

SCORES|
E-Voting Links|
CDSL E-voting NSDL E-voting|
Opening A Account| Filing A Complaints|
SW CAPITAL PVT LTD CIN No. : U67120MH1994PTC081512 | SW Capital Pvt. Ltd.> SEBI Regn. No :- NSE-CM/FO/CD- INZ000182531 | BSE-CM/FO/CD- INZ000182531 | CDSL DP : IN-DP-CDSL-272-2004
Copyright © 2011 -SW Capital Pvt Ltd. All rights reserved. Designed, developed & powered by C-MOTS Infotech (ISO 9001:2015 certified)